70 vs 120 W thulium:yttrium‐aluminium‐garnet 2 µm continuous‐wave laser for the treatment of benign prostatic hyperplasia: a systematic ex‐vivo evaluation
Authors:
- 13 July 2010
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 106 (3) , 368-372
Abstract
Study Type – Aetiology (case series) Level of Evidence 4 OBJECTIVE: To evaluate the ablative and haemostatic properties of the recently introduced 120‐W thulium:yttrium‐aluminium‐garnet (Tm‐YAG) laser and to assess these results against those of the previously introduced 70‐W Tm‐YAG laser. MATERIALS AND METHODS: The ex‐vivo model of the isolated blood‐perfused porcine kidney was used to determine the ablation capacity, haemostatic properties and coagulation depth of a 2 µm continuous‐wave Tm‐YAG laser. The energy was delivered using a 550‐µm and an 800‐µm bare‐ended fibre. The results of the recently introduced 120‐W Tm‐YAG were compared to the established 70‐W device. Kidney tissue was embedded for histological evaluation. After staining (haematoxylin and eosin, H&E; and NADH) of the specimen, the coagulation zone and depth of the necrotic tissue layer were measured. RESULTS: With increased power output, the mean ( sd ) rate of vaporization of tissue increased, from 9.80 (3.03) g/10 min at 70 W to 16.41 (5.2) g/10 min at 120 W using the 550 µm fibre. The total amount of ablated tissue using the 800 µm fibre was lower than with the 550 µm fibre. With increasing power output the bleeding rate remained stable in either group. Tissue penetration remained shallow, even with increasing power output. In contrast to H&E staining, where the coagulation zone was measured, NADH staining showed an inner zone of necrotic tissue, again with no difference between the 70‐ and the 120‐W Tm‐YAG. CONCLUSION: The 120‐W Tm‐YAG offers significantly higher ablation rates than the 70‐W device, and despite the increased rate of ablation with the 120‐W Tm‐YAG, the bleeding rate and depth of tissue penetration were comparable to those using the 70‐W device.Keywords
This publication has 18 references indexed in Scilit:
- Thulium:yttrium‐aluminium‐garnet laser prostatectomy in men with refractory urinary retentionBJU International, 2009
- Preliminary evaluation of a novel side‐fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex‐vivo and in‐vivo investigationsBJU International, 2009
- Systematic Evaluation of a Recently Introduced 2- μ m Continuous-Wave Thulium Laser for Vaporesection of the ProstateJournal of Endourology, 2008
- 980-nm Diode Laser: A Novel Laser Technology for Vaporization of the ProstateEuropean Urology, 2007
- The Diode Laser: A Novel Side-Firing Approach for Laser Vaporisation of the Human Prostate—Immediate Efficacy and 1-Year Follow-UpEuropean Urology, 2007
- RevoLix™ vaporesection of the prostate: initial results of 54 patients with a 1-year follow-upWorld Journal of Urology, 2007
- Current Role of Lasers in the Treatment of Benign Prostatic Hyperplasia (BPH)European Urology, 2006
- New Bipolar Resection Device for Transurethral Resection of the Prostate: First ex-Vivo and in-Vivo EvaluationJournal of Endourology, 2005
- Is transurethral resection of the prostate still justified?BJU International, 1999
- Rotoresect: New Technique for Resection of the Prostate: Experimental PhaseJournal of Endourology, 1996